Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The North America travel vaccines market size reached US$ 1.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2027, exhibiting a growth rate (CAGR) of 6.89% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc. 

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the North America travel vaccines market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on composition and disease.

  • Key Regions Analysed
    • United States
    • Canada
    • Mexico
       
  • Analysis for Each Country
     
  • Market by Composition
    • Mono Vaccines
    • Combination Vaccines
       
  • Market by Disease
    • Hepatitis A
    • DPT
    • Yellow Fever
    • Typhoid
    • Hepatitis B
    • Measles and Mumps
    • Rabies
    • Meningococcal
    • Varicella
    • Japanese Encephalitis
    • Others
       
  • Value Chain Analysis
  • Key Drivers and Challenges
  • Porters Five Forces Analysis
  • PESTEL Analysis
  • Government Regulations
  • Competitive Landscape
    • Competitive Structure
    • Key Player Profiles


Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Composition, Disease, Country
Countries Covered United States, Canada, Mexico
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Travel Vaccines Market
    5.1    Market Performance
    5.2    Market Breakup by Composition
    5.3    Market Breakup by Disease
    5.4    Market Breakup by Region 
    5.5    Market Forecast 
6   North America Travel Vaccines Market
    6.1    Market Performance
    6.2    Impact of COVID-19
    6.3    Market Forecast 
7   North America Travel Vaccines Market: Breakup by Composition
    7.1    Mono Vaccines
    7.2    Combination Vaccines
8   North America Travel Vaccines Market: Breakup by Disease
    8.1    Hepatitis A
    8.2    DPT
    8.3    Yellow Fever
    8.4    Typhoid
    8.5    Hepatitis B
    8.6    Measles and Mumps
    8.7    Rabies
    8.8    Meningococcal
    8.9    Varicella
    8.10    Japanese Encephalitis
    8.11    Others
9   North America Travel Vaccines Market: Breakup by Country 
    9.1   United States
     9.1.1    Historical Market Trends
     9.1.2    Market Breakup by Composition
     9.1.3    Market Breakup by Disease
     9.1.4    Market Forecast
    9.2   Canada
     9.2.1    Historical Market Trends
     9.2.2    Market Breakup by Composition 
     9.2.3    Market Breakup by Disease
     9.2.4    Market Forecast
    9.3   Mexico
     9.3.1    Historical Market Trends
     9.3.2    Market Breakup by Composition 
     9.3.3    Market Breakup by Disease
     9.3.4    Market Forecast
10  SWOT Analysis
    10.1    Overview 
    10.2    Strengths
    10.3    Weaknesses 
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
    11.1     Overview
    11.2     Exploratory Stage
    11.3     Preclinical and Clinical Development
    11.4     Regulatory Approval
    11.5     Manufacturing
    11.6     Marketing and Distribution
12  Porter’s Five Forces Analysis
    12.1     Overview
    12.2     Bargaining Power of Buyers
    12.3     Bargaining Power of Suppliers
    12.4     Degree of Rivalry
    12.5     Threat of New Entrants
    12.6     Threat of Substitutes
13  Price Analysis 
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players

List of Figures

Figure 1: North America: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Value Trends (in Billion US$), 2016-2021
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2021
Figure 6: Global: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 7: North America: Travel Vaccines Market: Value Trends (in Billion US$), 2016-2021
Figure 8: North America: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 9: North America: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 10: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million US$), 2016 & 2021
Figure 11: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 12: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million US$), 2016 & 2021
Figure 13: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 14: North America: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 15: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million US$), 2016 & 2021
Figure 16: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 17: North America: Travel Vaccines (DPT) Market: Value Trends (in Million US$), 2016 & 2021
Figure 18: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 19: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million US$), 2016 & 2021
Figure 20: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 21: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million US$), 2016 & 2021
Figure 22: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 23: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million US$), 2016 & 2021
Figure 24: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 25: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million US$), 2016 & 2021
Figure 26: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 27: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million US$), 2016 & 2021
Figure 28: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 29: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million US$), 2016 & 2021
Figure 30: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 31: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million US$), 2016 & 2021
Figure 32: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million US$), 2016 & 2021
Figure 34: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 35: North America: Travel Vaccines (Others) Market: Value Trends (in Million US$), 2016 & 2021
Figure 36: North America: Travel Vaccines (Others) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 37: North America: Travel Vaccines Market: Breakup by Country (in %), 2021
Figure 38: United States: Travel Vaccines Market: Value Trends (in Million US$), 2016-2021
Figure 39: United States: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 40: United States: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 41: United States: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 42: Canada: Travel Vaccines Market: Value Trends (in Million US$), 2016-2021
Figure 43: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 44: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 45: Canada: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 46: Mexico: Travel Vaccines Market: Value Trends (in Million US$), 2016-2021
Figure 47: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 48: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 49: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 50: North America: Travel Vaccines Industry: SWOT Analysis
Figure 51: North America: Travel Vaccines Industry: Value Chain Analysis
Figure 52: North America: Travel Vaccines Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2021 and 2027
Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2022-2027
Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2022-2027
Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million US$), 2022-2027
Table 5: North America: Travel Vaccines Market: Competitive Structure
Table 6: North America: Travel Vaccines Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The North America travel vaccines market was valued at US$ 1.7 Billion in 2021.

We expect the North America travel vaccines market to exhibit a CAGR of 6.89% during 2022-2027.

The high prevalence of travel-related diseases, such as influenza, meningitis, tick-borne encephalitis,
etc., is primarily driving the North America travel vaccines market.

The sudden outbreak of the COVID-19 pandemic has led to the rising adoption of novel coronavirus
vaccine as a mandate travel requirement for international travelers in North America to avoid the risk of
infection.

Based on the composition, the North America travel vaccines market has been segmented into mono vaccines and combination vaccines. Currently, combination vaccines hold the majority of the total
market share.

Based on the disease, the North America travel vaccines market can be divided into hepatitis A, DPT,
yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others. Among these, hepatitis A currently represents the largest market share.

On a regional level, the market has been classified into United States, Canada, and Mexico, where the
United States currently dominates the North American market.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2699

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links